Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss

Yukmijihwang-tang (YJ) has been used to treat diabetes mellitus, renal disorders, and cognitive impairment in traditional medicine. This study aimed to evaluate the anti-osteoporotic effect of YJ on ovariectomy (OVX)-induced bone loss in a rat and receptor activator of nuclear factor kappa-B ligand...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Sang-Yong Han, Yun-Kyung Kim
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Subjects:
Yukmijihwang-tang
osteoclast differentiation
RANKL
NFATc1
OVX
bone loss
Online Access:https://www.mdpi.com/1420-3049/26/24/7579

Internet

https://www.mdpi.com/1420-3049/26/24/7579

Similar Items